ATE456392T1 - Benzoädüisoxazol-derivate als c-kit-tyrosinkinase-hemmer zur behandlung von erkrankungen im zusammenhang mit der überproduktion von histamin - Google Patents
Benzoädüisoxazol-derivate als c-kit-tyrosinkinase-hemmer zur behandlung von erkrankungen im zusammenhang mit der überproduktion von histaminInfo
- Publication number
- ATE456392T1 ATE456392T1 AT07810594T AT07810594T ATE456392T1 AT E456392 T1 ATE456392 T1 AT E456392T1 AT 07810594 T AT07810594 T AT 07810594T AT 07810594 T AT07810594 T AT 07810594T AT E456392 T1 ATE456392 T1 AT E456392T1
- Authority
- AT
- Austria
- Prior art keywords
- kit
- treatment
- benzoadiisoxazole
- overproduction
- histamine
- Prior art date
Links
- 201000010099 disease Diseases 0.000 title abstract 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 4
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 title 2
- 229960001340 histamine Drugs 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 238000012261 overproduction Methods 0.000 title 1
- 102000016971 Proto-Oncogene Proteins c-kit Human genes 0.000 abstract 3
- 108010014608 Proto-Oncogene Proteins c-kit Proteins 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 3
- 230000001404 mediated effect Effects 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 208000023275 Autoimmune disease Diseases 0.000 abstract 1
- 206010020751 Hypersensitivity Diseases 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 230000007815 allergy Effects 0.000 abstract 1
- 230000003176 fibrotic effect Effects 0.000 abstract 1
- 210000003630 histaminocyte Anatomy 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/20—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US83230606P | 2006-07-20 | 2006-07-20 | |
| PCT/US2007/016328 WO2008011080A2 (en) | 2006-07-20 | 2007-07-18 | Benzo(d) isoxazole derivatives as c-kit tyrosine kinase inhibitors for the treatment of disorders associated with the over production of histamine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE456392T1 true ATE456392T1 (de) | 2010-02-15 |
Family
ID=38941934
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT07810594T ATE456392T1 (de) | 2006-07-20 | 2007-07-18 | Benzoädüisoxazol-derivate als c-kit-tyrosinkinase-hemmer zur behandlung von erkrankungen im zusammenhang mit der überproduktion von histamin |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US7872128B2 (de) |
| EP (1) | EP2069020B1 (de) |
| AT (1) | ATE456392T1 (de) |
| AU (1) | AU2007275653B2 (de) |
| CA (1) | CA2658359C (de) |
| DE (1) | DE602007004638D1 (de) |
| ES (1) | ES2338278T3 (de) |
| WO (1) | WO2008011080A2 (de) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI504395B (zh) | 2009-03-10 | 2015-10-21 | Substituted 3-amino-2-mercaptoquinoline as a KCNQ2 / 3 modifier | |
| MX2011008825A (es) | 2009-03-10 | 2011-09-21 | Gruenenthal Gmbh | 3-aminoisoxazolopiridinas sustituidas como moduladores de kcnq2/3. |
| TWI461197B (zh) | 2009-03-12 | 2014-11-21 | 2-mercaptoquinoline-3-carboxamide as a KCNQ2 / 3 modifier | |
| TWI475020B (zh) | 2009-03-12 | 2015-03-01 | The substituted nicotine amide as a KCNQ2 / 3 modifier | |
| TW201038565A (en) | 2009-03-12 | 2010-11-01 | Gruenenthal Gmbh | Substituted 2-mercapto-3-aminopyridines as KCNQ2/3 modulators |
| CA2789434A1 (en) * | 2010-02-11 | 2011-08-18 | Vanderbilt University | Benzisoxazoles and azabenzisoxazoles as mglur4 allosteric potentiators, compositions, and methods of treating neurological dysfunction |
| BR112013004562A2 (pt) | 2010-08-27 | 2016-09-06 | Gruenenthal Gmbh | 2-óxi-quinolina-3-carboxamidas substituídas como moduladores kcnq2/3 |
| SI2609086T1 (sl) | 2010-08-27 | 2015-04-30 | Gruenenthal Gmbh | Substituirani 2-okso in 2-tiokso-dihidrokinolin-3-karboksamidi kot KCNQ2/3 modulatorji |
| TW201211007A (en) | 2010-08-27 | 2012-03-16 | Gruenenthal Gmbh | Substituted 2-amino-quinoline-3-carboxamides as KCNQ2/3 modulators |
| MX2013002295A (es) | 2010-09-01 | 2013-05-09 | Gruenenthal Gmbh | 1-oxo-dihidroisoquinolin-3-carboxamidas sustituidas como moduladores de kcnq2/3. |
| BR112014001977A2 (pt) | 2011-07-27 | 2017-02-21 | Ab Science | inibidores seletivos de proteína quinase |
| PT2934145T (pt) * | 2012-12-19 | 2018-02-13 | Celgene Quanticel Res Inc | Inibidores de histona demetilase |
| WO2017027600A1 (en) * | 2015-08-12 | 2017-02-16 | Forum Pharmaceuticals, Inc. | GEMINAL SUBSTITUTED AMINOBENZISOXAZOLE COMPOUNDS AS AGONISTS OF α7-NICOTINIC ACETYLCHOLINE RECEPTORS |
| KR20210142154A (ko) | 2019-03-21 | 2021-11-24 | 옹쎄오 | 암 치료를 위한 키나제 억제제와 조합된 dbait 분자 |
| CN114761006A (zh) | 2019-11-08 | 2022-07-15 | Inserm(法国国家健康医学研究院) | 对激酶抑制剂产生耐药性的癌症的治疗方法 |
| WO2021148581A1 (en) | 2020-01-22 | 2021-07-29 | Onxeo | Novel dbait molecule and its use |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6271233B1 (en) * | 1999-08-10 | 2001-08-07 | Ciba Vision Corporation | Method for treating ocular neovascular diseases |
| US7202363B2 (en) | 2003-07-24 | 2007-04-10 | Abbott Laboratories | Thienopyridine and furopyridine kinase inhibitors |
-
2007
- 2007-07-18 DE DE602007004638T patent/DE602007004638D1/de active Active
- 2007-07-18 ES ES07810594T patent/ES2338278T3/es active Active
- 2007-07-18 EP EP07810594A patent/EP2069020B1/de active Active
- 2007-07-18 WO PCT/US2007/016328 patent/WO2008011080A2/en not_active Ceased
- 2007-07-18 US US11/879,831 patent/US7872128B2/en not_active Expired - Fee Related
- 2007-07-18 AU AU2007275653A patent/AU2007275653B2/en not_active Ceased
- 2007-07-18 AT AT07810594T patent/ATE456392T1/de not_active IP Right Cessation
- 2007-07-18 CA CA2658359A patent/CA2658359C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP2069020A2 (de) | 2009-06-17 |
| US7872128B2 (en) | 2011-01-18 |
| ES2338278T3 (es) | 2010-05-05 |
| WO2008011080A3 (en) | 2008-04-24 |
| US20080227779A1 (en) | 2008-09-18 |
| AU2007275653B2 (en) | 2010-12-23 |
| CA2658359C (en) | 2011-11-29 |
| AU2007275653A1 (en) | 2008-01-24 |
| DE602007004638D1 (de) | 2010-03-18 |
| CA2658359A1 (en) | 2008-01-24 |
| WO2008011080A2 (en) | 2008-01-24 |
| EP2069020B1 (de) | 2010-01-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE456392T1 (de) | Benzoädüisoxazol-derivate als c-kit-tyrosinkinase-hemmer zur behandlung von erkrankungen im zusammenhang mit der überproduktion von histamin | |
| ATE469144T1 (de) | Substituierte pyridonverbindungen und anwendungsverfahren | |
| EA200900779A1 (ru) | Производные дигидропиридина, полезные как ингибиторы протеинкиназы | |
| EA201001769A1 (ru) | Производные хинолинов и хиноксалинов в качестве ингибиторов протеинтирозинкиназы | |
| NO20083214L (no) | Pyrimidinylarylurea-derivater som omdannes til FGF-inhibitorer | |
| WO2006039718A3 (en) | Aryl nitrogen-containing bicyclic compounds and their use as kinase inhibitors | |
| WO2008011110A3 (en) | Di-amino-substituted heterocyclic compounds and methods of use | |
| WO2006044823A3 (en) | Heteroaryl-substituted alkyne compounds and method of use | |
| ATE362932T1 (de) | Azaindolverbindungen als kinaseinhibitoren | |
| DE602006011482D1 (de) | Regioselektives verfahren zur zubereitung von benzimidazol-thiophenen | |
| EA201000092A1 (ru) | Тризамещенные пиримидиновые производные для лечения пролиферативных заболеваний | |
| EA201201677A1 (ru) | Производные гетероарилимидазолона в качестве ингибиторов jak | |
| ATE390925T1 (de) | Verwendung von substituierten chinolin-derivaten zur behandlung von arzneimittelresistenten mycobakteriellen erkrankungen | |
| EA201071045A1 (ru) | Соединения оксадиазоантрацена для лечения диабета | |
| UA96565C2 (ru) | Пиридильные ингибиторы хеджхоговской передачи сигнала | |
| EA201000090A1 (ru) | Тризамещенные производные пиримидина для лечения пролиферативных заболеваний | |
| EA201101650A1 (ru) | Новые производные пиримидина и их применение в лечении злокачественных новообразований и последующих заболеваний | |
| EA201000091A1 (ru) | ПРОИЗВОДНЫЕ МОРФОЛИНОПИРИМИДИНА, ИСПОЛЬЗУЕМЫЕ ПРИ ЗАБОЛЕВАНИЯХ, СВЯЗАННЫХ С mTOR КИНАЗОЙ И/ИЛИ PI3K | |
| EA201500182A1 (ru) | 4-МЕТИЛ-2,3,5,9,9b-ПЕНТААЗАЦИКЛОПЕНТА[a]НАФТАЛИНЫ | |
| EA200970402A1 (ru) | Триазолопиридазиновые модуляторы протеинкиназ | |
| NO20083639L (no) | Aurorakinasemodulatorer og fremgangsmate for anvendelse | |
| NO20063821L (no) | Kinolinderivater for anvendelse som mykobakterielle inhibitorer | |
| TW200745066A (en) | Novel PTP1B inhibitors | |
| EA201071307A1 (ru) | Карбамоильные производные бициклических карбониламинопиразолов в качестве пролекарств | |
| DE602005022284D1 (de) | Substituierte benzimidazole und deren verwendung zur induktion von apoptose |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |